β-hydroxybutyrate restrains colitis-associated tumorigenesis by inhibiting HIF-1α-mediated angiogenesis.
Huang C, Tan H, Wang J, Huang L, Liu H, Shi Y, Zhong C, Weng S, Chen C, Zhao W, Lin Z, Li J, Zhi F, Zhang B.
Huang C, et al. Among authors: weng s.
Cancer Lett. 2024 Jul 1;593:216940. doi: 10.1016/j.canlet.2024.216940. Epub 2024 May 8.
Cancer Lett. 2024.
PMID: 38729554